The DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
NKG2D ligands in tumor immunity
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
Cancer regression in patients after transfer of genetically engineered lymphocytes
Morgan, R. A., Dudley, M. E., Wunderlich, J. R., Hughes, M. S., Yang, J. C., Sherry, R. M., Royal, R. E., Topalian, S. L., Kammula, U. S., Restifo, N. P., et al. (2006) · Science · doi:10.1126/science.1129003 · Cited by 2,603
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
Groh, V., Wu, J., Yee, C., & Spies, T. (2002) · Nature · doi:10.1038/nature01112 · Cited by 1,592
DNA damage-induced cell death by apoptosis
Roos, W. P., & Kaina, B. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.07.007 · Cited by 1,500
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
Gasser, S., Orsulic, S., Brown, E. J., & Raulet, D. H. (2005) · Nature · doi:10.1038/nature03884 · Cited by 1,308
Cosman, D., Müllberg, J., Sutherland, C. L., Chin, W., Armitage, R., Fanslow, W., Kubin, M., & Chalupny, N. J. (2001) · Immunity · doi:10.1016/s1074-7613(01)00095-4 · Cited by 1,232
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
Diefenbach, A., Jensen, E. R., Jamieson, A. M., & Raulet, D. H. (2001) · Nature · doi:10.1038/35093109 · Cited by 1,083
An Activating Immunoreceptor Complex Formed by NKG2D and DAP10
Wu, J., Song, Y., Bakker, A. B. H., Bauer, S., Spies, T., Lanier, L. L., & Phillips, J. H. (1999) · Science · doi:10.1126/science.285.5428.730 · Cited by 1,039
Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., & Spies, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6879 · Cited by 1,028
Groh, V, Bahram, S., Bauer, S., Herman, A., Beauchamp, M., & Spies, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12445 · Cited by 1,017
Regulation of Cutaneous Malignancy by γδ T Cells
Girardi, M., Oppenheim, D. E., Steele, C. R., Lewis, J. M., Glusac, E., Filler, R., Hobby, P., Sutton, B., Tigelaar, R. E., & Hayday, A. C. (2001) · Science · doi:10.1126/science.1063916 · Cited by 1,004
Ghiringhelli, F., Ménard, C., Terme, M., Flament, C., Taieb, J., Chaput, N., Puig, P. E., Novault, S., Escudier, B., Vivier, E., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051511 · Cited by 949
Dendritic Cells Prime Natural Killer Cells by trans-Presenting Interleukin 15
Lucas, M., Schachterle, W., Oberle, K., Aichele, P., & Diefenbach, A. (2007) · Immunity · doi:10.1016/j.immuni.2007.03.006 · Cited by 887
Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N., & Raulet, D. H. (2000) · Nature Immunology · doi:10.1038/77793 · Cited by 878
Bryceson, Y. T., March, M. E., Ljunggren, H.-G., & Long, E. O. (2006) · Blood · doi:10.1182/blood-2005-04-1351 · Cited by 863
Meresse, B., Chen, Z., Ciszewski, C., Tretiakova, M., Bhagat, G., Krausz, T. N., Raulet, D. H., Lanier, L. L., Groh, V., Spies, T., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.06.020 · Cited by 855
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy
Guerra, N., Tan, Y. X., Joncker, N. T., Choy, A., Gallardo, F., Xiong, N., Knoblaugh, S., Cado, D., Greenberg, N. R., & Raulet, D. H. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.016 · Cited by 850
A second lineage of mammalian major histocompatibility complex class I genes.
Bahram, S., Bresnahan, M., Geraghty, D. E., & Spies, T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6259 · Cited by 784
A Direct Role for NKG2D/MICA Interaction in Villous Atrophy during Celiac Disease
Hüe, S., Mention, J.-J., Monteiro, R. C., Zhang, S., Cellier, C., Schmitz, J., Verkarre, V., Fodil, N., Bahram, S., Cerf-Bensussan, N., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.06.018 · Cited by 759
Castriconi, R., Cantoni, C., Della Chiesa, M., Vitale, M., Marcenaro, E., Conte, R., Biassoni, R., Bottino, C., Moretta, L., & Moretta, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730640100 · Cited by 726
Retinoic Acid Early Inducible Genes Define a Ligand Family for the Activating NKG2D Receptor in Mice
Cerwenka, A., Bakker, A. B. H., McClanahan, T., Wagner, J., Wu, J., Phillips, J. H., & Lanier, L. L. (2000) · Immunity · doi:10.1016/s1074-7613(00)80222-8 · Cited by 695
Self-citationThe Role of the NKG2D Immunoreceptor in Immune Cell Activation and Natural Killing
Jamieson, A. M., Diefenbach, A., McMahon, C. W., Xiong, N., Carlyle, J. R., & Raulet, D. H. (2002) · Immunity · doi:10.1016/s1074-7613(02)00333-3 · Cited by 647
Cutting Edge: Down-Regulation of MICA on Human Tumors by Proteolytic Shedding
Salih, H. R., Rammensee, H.-G., & Steinle, A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4098 · Cited by 643
Cerwenka, A., Baron, J. L., & Lanier, L. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201238598 · Cited by 606
Self-citationLee, J.-C., Lee, K.-M., Kim, D.-W., & Heo, D. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7335 · Cited by 549
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia
Salih, H. R., Antropius, H., Gieseke, F., Lutz, S. Z., Kanz, L., Rammensee, H.-G., & Steinle, A. (2003) · Blood · doi:10.1182/blood-2003-01-0019 · Cited by 541
Groh, V., Brühl, A., El-Gabalawy, H., Nelson, J. L., & Spies, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1632807100 · Cited by 506
Pende, D., Rivera, P., Marcenaro, S., Chang, C., Biassoni, R., Conte, R., Kubin, M. Z., Cosman, D. J., Ferrone, S., Moretta, L., et al. (2002) · PubMed · Cited by 500
Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts
Paloneva, J., Kestilä, M., Wu, J., Salminen, A., Böhling, T., Ruotsalainen, V., Hakola, P., Bakker, A. B. H., Phillips, J. H., Pekkarinen, P., et al. (2000) · Nature Genetics · doi:10.1038/77153 · Cited by 460
Steinle, A., Li, P., Morris, D. L., Groh, V., Lanier, L. L., Strong, R. K., & Spies, T. (2001) · Immunogenetics · doi:10.1007/s002510100325 · Cited by 454
Oppenheim, D. E., Roberts, S. J., Clarke, S. L., Filler, R., Lewis, J. M., Tigelaar, R. E., Girardi, M., & Hayday, A. C. (2005) · Nature Immunology · doi:10.1038/ni1239 · Cited by 454
Diefenbach, A., Tomasello, E., Lucas, M., Jamieson, A. M., Hsia, J. K., Vivier, E., & Raulet, D. H. (2002) · Nature Immunology · doi:10.1038/ni858 · Cited by 452
Houchins, J. P., Yabe, T., McSherry, C., & Bach, F. H. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.4.1017 · Cited by 447
NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation
Gilfillan, S., Ho, E. L., Cella, M., Yokoyama, W. M., & Colonna, M. (2002) · Nature Immunology · doi:10.1038/ni857 · Cited by 437
CD4+CD25+ T Regulatory Cells Suppress NK Cell-Mediated Immunotherapy of Cancer
Smyth, M. J., Teng, M. W. L., Swann, J., Kyparissoudis, K., Godfrey, D. I., & Hayakawa, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1582 · Cited by 420
Function and regulation of AP-1 subunits in skin physiology and pathology
Angel, P., Szabowski, A., & Schorpp-Kistner, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204380 · Cited by 408
A novel dendritic cell subset involved in tumor immunosurveillance
Taieb, J., Chaput, N., Ménard, C., Apetoh, L., Ullrich, E., Bonmort, M., Péquignot, M., Casares, N., Terme, M., Flament, C., et al. (2006) · Nature Medicine · doi:10.1038/nm1356 · Cited by 405
Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity
Chan, C. W., Crafton, E., Fan, H.-N., Flook, J., Yoshimura, K., Skarica, M., Brockstedt, D., Dubensky, T. W., Stins, M. F., Lanier, L. L., et al. (2006) · Nature Medicine · doi:10.1038/nm1352 · Cited by 399
Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells
Verneris, M. R., Karami, M., Baker, J., Jayaswal, A., & Negrin, R. S. (2004) · Blood · doi:10.1182/blood-2003-06-2125 · Cited by 383
Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands
Kaiser, B. K., Yim, D., Chow, I.-T., Gonzalez, S., Dai, Z., Mann, H. H., Strong, R. K., Groh, V., & Spies, T. (2007) · Nature · doi:10.1038/nature05768 · Cited by 377
Promiscuity and the single receptor: NKG2D
Eagle, R. A., & Trowsdale, J. (2007) · Nature Reviews Immunology · doi:10.1038/nri2144 · Cited by 374
Armeanu, S., Bitzer, M., Lauer, U. M., Venturelli, S., Pathil, A., Krusch, M., Kaiser, S., Jobst, J., Smirnow, I., Wagner, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4252 · Cited by 358
NKG2D function protects the host from tumor initiation
Smyth, M. J., Swann, J., Cretney, E., Zerafa, N., Yokoyama, W. M., & Hayakawa, Y. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050994 · Cited by 342
Roberts, A. I., Lee, L., Schwarz, E., Groh, V., Spies, T., Ebert, E. C., & Jabri, B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5527 · Cited by 335
Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host
Liu, C., Yu, S., Kappes, J., Wang, J., Grizzle, W. E., Zinn, K. R., & Zhang, H.-G. (2007) · Blood · doi:10.1182/blood-2006-09-046201 · Cited by 335
Carbone, E. (2005) · Blood · doi:10.1182/blood-2004-04-1422 · Cited by 333
Evasion from NK Cell Immunity by MHC Class I Chain-Related Molecules Expressing Colon Adenocarcinoma
Doubrovina, E. S., Doubrovin, M. M., Vider, E., Sisson, R. B., O’Reilly, R. J., Dupont, B., & Vyas, Y. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6891 · Cited by 324
El-Sherbiny, Y. M., Meade, J. L., Holmes, T. D., McGonagle, D., Mackie, S. L., Morgan, A. W., Cook, G., Feyler, S., Richards, S. J., Davies, F. E., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4230 · Cited by 321
Friese, M. A., Wischhusen, J., Wick, W., Weiler, M., Eisele, G., Steinle, A., & Weller, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1627 · Cited by 305
Hamerman, J. A., Ogasawara, K., & Lanier, L. L. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.11.001 · Cited by 304
Cerboni, C., Zingoni, A., Cippitelli, M., Piccoli, M., Frati, L., & Santoni, A. (2007) · Blood · doi:10.1182/blood-2006-10-052720 · Cited by 297
Nedvetzki, S., Sowinski, S., Eagle, R. A., Harris, J., Vély, F., Pende, D., Trowsdale, J., Vivier, E., Gordon, S., & Davis, D. M. (2007) · Blood · doi:10.1182/blood-2006-10-052977 · Cited by 283
Carayannopoulos, L. N., Naidenko, O. V., Fremont, D. H., & Yokoyama, W. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4079 · Cited by 274
Downregulation and/or Release of NKG2D Ligands as Immune Evasion Strategy of Human Neuroblastoma
Raffaghello, L., Prigione, I., Airoldi, I., Camoriano, M., Levreri, I., Gambini, C., Pende, D., Steinle, A., Ferrone, S., & Pistoia, V. (2004) · Neoplasia · doi:10.1593/neo.04316 · Cited by 264
Jinushi, M., Takehara, T., Kanto, T., Tatsumi, T., Groh, V., Spies, T., Miyagi, T., Suzuki, T., Sasaki, Y., & Hayashi, N. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1249 · Cited by 260
Jinushi, M., Vanneman, M., Munshi, N. C., Tai, Y.-T., Prabhala, R. H., Ritz, J., Neuberg, D., Anderson, K. C., Carrasco, D. R., & Dranoff, G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711293105 · Cited by 256
Ligands for natural killer cell receptors: redundancy or specificity
Cerwenka, A., & Lanier, L. L. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1810113.x · Cited by 248
Self-citationProteolytic Release of Soluble UL16-Binding Protein 2 from Tumor Cells
Waldhauer, I., & Steinle, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2520 · Cited by 245
Jinushi, M., Takehara, T., Tatsumi, T., Kanto, T., Groh, V., Spies, T., Kimura, R., Miyagi, T., Mochizuki, K., Sasaki, Y., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.10966 · Cited by 244
Soluble MICA in malignant diseases
Holdenrieder, S., Stieber, P., Peterfi, A., Nagel, D., Steinle, A., & Salih, H. R. (2006) · International Journal of Cancer · doi:10.1002/ijc.21382 · Cited by 240
Systemic NKG2D Down-Regulation Impairs NK and CD8 T Cell Responses In Vivo
Wiemann, K., Mittrücker, H.-W., Feger, U., Welte, S. A., Yokoyama, W. M., Spies, T., Rammensee, H.-G., & Steinle, A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.720 · Cited by 240
Tieng, V., Le Bouguénec, C., du Merle, L., Bertheau, P., Desreumaux, P., Janin, A., Charron, D., & Toubert, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032668099 · Cited by 235
Carlsten, M., Björkström, N. K., Norell, H., Bryceson, Y., van Hall, T., Baumann, B. C., Hanson, M., Schedvins, K., Kiessling, R., Ljunggren, H.-G., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2264 · Cited by 234
The Molecular and Functional Characterization of a Dominant Minor H Antigen, H60
Malarkannan, S., Shih, P. P., Eden, P. A., Horng, T., Zuberi, A. R., Christianson, G., Roopenian, D., & Shastri, N. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3501 · Cited by 233
Regulatory T Cells in Ovarian Cancer: Biology and Therapeutic Potential
Barnett, B., Kryczek, I., Cheng, P., Zou, W., & Curiel, T. J. (2005) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2005.00330.x · Cited by 233
Pillarisetty, V. G., Shah, A. B., Miller, G., Bleier, J. I., & DeMatteo, R. P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.1009 · Cited by 232
Allez, M., Tieng, V., Nakazawa, A., Treton, X., Pacault, V., Dulphy, N., Caillat–Zucman, S., Paul, P., Gornet, J., Douay, C., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.025 · Cited by 231
Coudert, J. D., Zimmer, J., Tomasello, E., Cebecauer, M., Colonna, M., Vivier, E., & Held, W. (2005) · Blood · doi:10.1182/blood-2005-03-0918 · Cited by 226
Activated, But Not Resting, T Cells Can Be Recognized and Killed by Syngeneic NK Cells
Rabinovich, B. A., Li, J., Shannon, J., Hurren, R., Chalupny, J., Cosman, D., & Miller, R. G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3572 · Cited by 223
Jinushi, M., Takehara, T., Tatsumi, T., Hiramatsu, N., Sakamori, R., Yamaguchi, S., & Hayashi, N. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.05.026 · Cited by 220
Diermayr, S., Himmelreich, H., Durovic, B., Mathys-Schneeberger, A., Siegler, U., Langenkamp, U., Hofsteenge, J., Gratwohl, A., Tichelli, A., Paluszewska, M., et al. (2008) · Blood · doi:10.1182/blood-2007-07-101311 · Cited by 220
Eisele, G. (2006) · Brain · doi:10.1093/brain/awl205 · Cited by 219
Cutting Edge: Toll-Like Receptor Signaling in Macrophages Induces Ligands for the NKG2D Receptor
Hamerman, J. A., Ogasawara, K., & Lanier, L. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2001 · Cited by 205
Garrity, D., Call, M. E., Feng, J., & Wucherpfennig, K. W. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502439102 · Cited by 205
ULBP4 is a novel ligand for human NKG2D
Jan Chalupny, N., Sutherland, C. L., Lawrence, W. A., Rein-Weston, A., & Cosman, D. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00714-9 · Cited by 202
Nowbakht, P., Ionescu, M.-C. S., Rohner, A., Kalberer, C. P., Rossy, E., Mori, L., Cosman, D., De Libero, G., & Wodnar-Filipowicz, A. (2005) · Blood · doi:10.1182/blood-2004-07-2585 · Cited by 196
MICA/NKG2D-mediated immunogene therapy of experimental gliomas.
Friese, M. A., Platten, M., Lutz, S. Z., Naumann, U., Aulwurm, S., Bischof, F., Bühring, H. ‐., DICHGANS, J., Rammensee, H., Steinle, A., et al. (2003) · PubMed · Cited by 193
Venkataraman, G. M., Suciu, D., Groh, V., Boss, J. M., & Spies, T. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.961 · Cited by 191
Ward, J., Bonaparte, M., Sacks, J., Guterman, J., Fogli, M., Mavilio, D., & Barker, E. (2007) · Blood · doi:10.1182/blood-2006-06-028175 · Cited by 190
Poggi, A., Venturino, C., Catellani, S., Clavio, M., Miglino, M., Gobbi, M., Steinle, A., Ghia, P., Stella, S., Caligaris-Cappio, F., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2417 · Cited by 188
Two Human ULBP/RAET1 Molecules with Transmembrane Regions Are Ligands for NKG2D
Bacon, L., Eagle, R. A., Meyer, M., Easom, N., Young, N. T., & Trowsdale, J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1078 · Cited by 184
Pappworth, I. Y., Wang, E. C., & Rowe, M. (2007) · Journal of Virology · doi:10.1128/jvi.01777-06 · Cited by 178
Expression of Stress-induced MHC Class I Related Chain Molecules on Human Melanoma
Vetter, C. S., Groh, V., Straten, P. T., Spies, T., Bröcker, E.-B., & Becker, J. C. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01700.x · Cited by 171
A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity
Diefenbach, A., Hsia, J. K., Hsiung, M. B., & Raulet, D. H. (2003) · European Journal of Immunology · doi:10.1002/immu.200310012 · Cited by 170
NKG2D Recognition and Perforin Effector Function Mediate Effective Cytokine Immunotherapy of Cancer
Smyth, M. J., Swann, J., Kelly, J. M., Cretney, E., Yokoyama, W. M., Diefenbach, A., Sayers, T. J., & Hayakawa, Y. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041522 · Cited by 169
Function of NKG2D in natural killer cell–mediated rejection of mouse bone marrow grafts
Ogasawara, K., Benjamin, J., Takaki, R., Phillips, J. H., & Lanier, L. L. (2005) · Nature Immunology · doi:10.1038/ni1236 · Cited by 169
NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway
Horng, T., Bezbradica, J. S., & Medzhitov, R. (2007) · Nature Immunology · doi:10.1038/ni1524 · Cited by 168
A Structural Basis for the Association of DAP12 with Mouse, but Not Human, NKG2D1
Rosen, D., Araki, M., Hamerman, J., Chen, T., Yamamura, T., & Lanier, L. (2004) · Journal of Immunology · doi:10.4049/jimmunol.173.4.2470 · Cited by 167
Fas ligand–mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity
Groh, V., Smythe, K., Dai, Z., & Spies, T. (2006) · Nature Immunology · doi:10.1038/ni1350 · Cited by 167
Watson, N. F. S., Spendlove, I., Madjd, Z., McGilvray, R., Green, A. R., Ellis, I. O., Scholefield, J. H., & Durrant, L. G. (2006) · International Journal of Cancer · doi:10.1002/ijc.21510 · Cited by 166
A Cluster of Ten Novel MHC Class I Related Genes on Human Chromosome 6q24.2–q25.3
Radosavljevic, M., Cuillerier, B., Wilson, M. J., Clément, O., Wicker, S., Gilfillan, S., Beck, S., Trowsdale, J., & Bahram, S. (2002) · Genomics · doi:10.1006/geno.2001.6673 · Cited by 160
Regulation of ligands for the activating receptor NKG2D
Mistry, A. R., & O'Callaghan, C. A. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02652.x · Cited by 160
Ho, E., Heusel, J. W., Brown, M. G., Matsumoto, K., Scalzo, A., & Yokoyama, W. (1998) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.95.11.6320 · Cited by 158
Dasgupta, S., Bhattacharya-Chatterjee, M., O’Malley, B. W., & Chatterjee, S. K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5541 · Cited by 158
Release of MICB Molecules by Tumor Cells: Mechanism and Soluble MICB in Sera of Cancer Patients
Salih, H. R., Goehlsdorf, D., & Steinle, A. (2006) · Human Immunology · doi:10.1016/j.humimm.2006.02.008 · Cited by 157
Chimeric NK-receptor–bearing T cells mediate antitumor immunotherapy
Zhang, T., Lemoi, B. A., & Sentman, C. L. (2005) · Blood · doi:10.1182/blood-2004-11-4365 · Cited by 157
CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells
Vosshenrich, C. A. J., Lesjean‐Pottier, S., Hasan, M., Goff, O. R.-L., Corcuff, E., Mandelboim, O., & Santo, J. P. D. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071451 · Cited by 157
Boissel, N., Réa, D., Tieng, V., Dulphy, N., Brun, M., Cayuela, J., Rousselot, P. H., Tamouza, R., Bouteiller, P. P. L., Mahon, F., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.5108 · Cited by 156
Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60.
O'Callaghan, C., Cerwenka, A., Willcox, B. E., Lanier, L., & Bjorkman, P. (2001) · Immunity · doi:10.1016/s1074-7613(01)00187-x · Cited by 142
Self-citationHoldenrieder, S., Stieber, P., Peterfi, A., Nagel, D., Steinle, A., & Salih, H. R. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0167-1 · Cited by 140
IL-21 Down-Regulates NKG2D/DAP10 Expression on Human NK and CD8+ T Cells1
Burgess, S., Marusina, A., Pathmanathan, I., Borrego, F., & Coligan, J. (2006) · Journal of Immunology · doi:10.4049/jimmunol.176.3.1490 · Cited by 140
Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression
Song, H., Kim, J.-K., Cosman, D. J., & Choi, I. (2006) · Cellular Immunology · doi:10.1016/j.cellimm.2006.03.002 · Cited by 132
IL-21 Enhances Tumor Rejection through a NKG2D-Dependent Mechanism
Takaki, R., Hayakawa, Y., Nelson, A., Sivakumar, P. V., Hughes, S. D., Smyth, M. J., & Lanier, L. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2167 · Cited by 130
NKG2D in NK and T Cell-Mediated Immunity
Ogasawara, K., & Lanier, L. L. (2005) · Journal of Clinical Immunology · doi:10.1007/s10875-005-8786-4 · Cited by 129
Glienke, J., Sobanov, Y., Brostjan, C., Steffens, C., Nguyen, C., Lehrach, H., Hofer, E., & Francis, F. (1998) · Immunogenetics · doi:10.1007/s002510050420 · Cited by 120
Chang, C., Dietrich, J., Harpur, A. G., Lindquist, J. A., Haude, A., Loke, Y. W., King, A., Colonna, M., Trowsdale, J., & Wilson, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.4651 · Cited by 120
In Vivo Expression Pattern of MICA and MICB and Its Relevance to Auto-Immunity and Cancer
Schrambach, S., Ardizzone, M., Leymarie, V., Sibilia, J., & Bahram, S. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000518 · Cited by 118
Märten, A., von Lilienfeld‐Toal, M., Büchler, M. W., & Schmidt, J. (2006) · International Journal of Cancer · doi:10.1002/ijc.22186 · Cited by 116
Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus
Vilarinho, S., Ogasawara, K., Nishimura, S. L., Lanier, L. L., & Baron, J. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708968104 · Cited by 116
MIC and other NKG2D ligands: from none to too many
Bahram, S., Inoko, H., Shiina, T., & Radosavljevic, M. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.07.016 · Cited by 116
NF-κB Regulates Expression of the MHC Class I-Related Chain A Gene in Activated T Lymphocytes
Molinero, L. L., Fuertes, M. B., Girart, M. V., Fainboim, L., Rabinovich, G. A., Costas, M. A., & Zwirner, N. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5583 · Cited by 116
Sirén, J., Sareneva, T., Pirhonen, J., Strengell, M., Veckman, V., Julkunen, I., & Matikainen, S. (2004) · Journal of General Virology · doi:10.1099/vir.0.80105-0 · Cited by 114
Ehrlich, L. I. R., Ogasawara, K., Hamerman, J., Takaki, R., Zingoni, A., Allison, J., & Lanier, L. (2005) · Journal of Immunology · doi:10.4049/jimmunol.174.4.1922 · Cited by 113
Rohner, A., Langenkamp, U., Siegler, U., Kalberer, C. P., & Wodnar‐Filipowicz, A. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.02.020 · Cited by 111
IFN-Dependent Down-Regulation of the NKG2D Ligand H60 on Tumors
Bui, J. D., Carayannopoulos, L. N., Lanier, L. L., Yokoyama, W. M., & Schreiber, R. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.905 · Cited by 104
Nomura, M., Zou, Z., Joh, T., Takihara, Y., Matsuda, Y., & Shimada, K. (1996) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021517 · Cited by 99
Roda‐Navarro, P., Valés‐Gómez, M., Chisholm, S. E., & Reyburn, H. T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600721103 · Cited by 97
Takada, A., Yoshida, S., Kajikawa, M., Miyatake, Y., Tomaru, U., Sakai, M., Chiba, H., Maenaka, K., Kohda, D., Fugo, K., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1678 · Cited by 91
Zou, Z., Nomura, M., Takihara, Y., Yasunaga, T., & 島田, 和. (1996) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021242 · Cited by 91
Zhang, T., Barber, A., & Sentman, C. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2251 · Cited by 83
Activation-induced expression of MICA on T lymphocytes involves engagement of CD3 and CD28
Molinero, L. L., Fuertes, M. B., Rabinovich, G. A., Fainboim, L., & Zwirner, N. W. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.5.791 · Cited by 81
Cao, W., Xi, X., Hao, Z., Li, W., Kong, Y., Cui, L., Ma, C., Ba, D., & He, W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702504200 · Cited by 80
In vivo selection for metastasis promoting genes in the mouse
Gumireddy, K., Sun, F., Klein–Szanto, A. J., Gibbins, J. M., Gimotty, P. A., Saunders, A. J., Schultz, P. G., & Huang, Q. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701145104 · Cited by 80
Castriconi, R., Dondero, A., Negri, F., et al. (2007) · European Journal of Immunology · doi:10.1002/eji.200737546 · Cited by 78
Routes, J. M., Ryan, S., Morris, K. R., Takaki, R., Cerwenka, A., & Lanier, L. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050240 · Cited by 74
Self-citationMechanisms Involved in Synergistic Anticancer Immunity of Anti-4-1BB and Anti-CD4 Therapy
Choi, B. K., Kim, Y. H., Kang, W. J., Lee, S. K., Kim, K. H., Shin, S. M., Yokoyama, W. M., Kim, T. Y., & Kwon, B. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1056 · Cited by 72
Zhang, J., Sun, R., Wei, H., Zhang, J., & Tian, Z. (2004) · PubMed · Cited by 71
Zhang, C., Zhang, J., Sun, R., Feng, J., Wei, H., & Tian, Z. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2005.02.003 · Cited by 70
Maccalli, C., Pende, D., Castelli, C., Mingari, M. C., Robbins, P. F., & Parmiani, G. (2003) · European Journal of Immunology · doi:10.1002/eji.200323909 · Cited by 62
Strong, R. K. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00032-9 · Cited by 60
Catellani, S., Poggi, A. D., Bruzzone, A., Dadati, P., Ravetti, J. L., Gobbi, M., & Zocchi, M. R. (2006) · Blood · doi:10.1182/blood-2006-06-028985 · Cited by 59
The NKG2D-Activating Receptor Mediates Pulmonary Clearance ofPseudomonas aeruginosa
Borchers, M. T., Harris, N. L., Wesselkamper, S. C., Zhang, S., Chen, Y., Young, L., & Lau, G. W. (2006) · Infection and Immunity · doi:10.1128/iai.74.5.2578-2586.2006 · Cited by 59
Song, H., Hur, D. Y., Kim, K.-E., Park, H., Kim, T. S., Kim, C.-W., Bang, S., & Cho, D.-H. (2006) · Cellular Immunology · doi:10.1016/j.cellimm.2006.09.002 · Cited by 55
Nausch, N., Florin, L., Hartenstein, B., Angel, P. E., Schorpp‐Kistner, M., & Cerwenka, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.7 · Cited by 54
Self-citationDNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor
Zhou, H., Luo, Y., Lo, J., Kaplan, C. D., Mizutani, M., Mizutani, N., Lee, J.-D., Primus, F. J., Becker, J. C., Xiang, R., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502208102 · Cited by 49
Roda‐Navarro, P., & Reyburn, H. T. (2007) · The FASEB Journal · doi:10.1096/fj.06-7488rev · Cited by 42
Rausch, A., Heßmann, M., Hölscher, A., Schreiber, T., Bulfone‐Paus, S., Ehlers, S., & Hölscher, C. (2006) · European Journal of Immunology · doi:10.1002/eji.200535290 · Cited by 42
Weizman, N., Shiloh, Y., & Barzilai, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211168200 · Cited by 40
NKG2D-independent suppression of T cell proliferation by H60 and MICA
Kriegeskorte, A. K., Gebhardt, F. E., Porcellini, S., Schiemann, M., Stemberger, C., Franz, T. J., Huster, K. M., Carayannopoulos, L. N., Yokoyama, W. M., Colonna, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502026102 · Cited by 39
NKG2D splice variants: a reexamination of adaptor molecule associations
Rabinovich, B. A., Li, J. S. Y., Wolfson, M. F., Lawrence, W., Beers, C., Chalupny, J., Hurren, R., Greenfield, B., Miller, R. G., & Cosman, D. J. (2006) · Immunogenetics · doi:10.1007/s00251-005-0078-x · Cited by 36
The treatment of melanoma with an emphasis on immunotherapeutic strategies
Jack, A., Boyes, C., Aydin, N., Alam, K., & Wallack, M. K. (2006) · Surgical Oncology · doi:10.1016/j.suronc.2006.05.003 · Cited by 35
A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor
Zhou, H., Luo, Y., Kaplan, C., Krüger, J. A., Lee, S., Xiang, R., & Reisfeld, R. A. (2005) · Blood · doi:10.1182/blood-2005-10-4231 · Cited by 25
Yokoyama, W. M. (2002) · Nature · doi:10.1038/419679a · Cited by 22
TNFα stimulates NKG2D-mediated lytic activity of acute myeloid leukemic cells
Guilloton, F., de Thonel, A., Jean, C., Demur, C., Mas, V. M., Laurent, G., & Quillet‐Mary, A. (2005) · Leukemia · doi:10.1038/sj.leu.2403952 · Cited by 21
Teng, M. W. L., Kershaw, M. H., Hayakawa, Y., Cerruti, L., Jane, S. M., Darcy, P. K., & Smyth, M. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505331200 · Cited by 12
Li, J. S. Y., Rabinovich, B. A., Hurren, R., Cosman, D. J., & Miller, R. G. (2005) · European Journal of Immunology · doi:10.1002/eji.200425621 · Cited by 11
Cited by
NK cells and cancer: you can teach innate cells new tricks
Morvan, M. G., & Lanier, L. L. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2015.5 · Cited by 1,162
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Labani-Motlagh, A., Ashja-Mahdavi, M., & Loskog, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00940 · Cited by 751
Circulating and disseminated tumour cells — mechanisms of immune surveillance and escape
Mohme, M., Riethdorf, S., & Pantel, K. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.144 · Cited by 602
Regulation of immune cell function and differentiation by the NKG2D receptor
Zafirova, B., Wensveen, F. M., Gulin, M., & Polić, B. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0797-0 · Cited by 538
The immune system in cancer metastasis: friend or foe?
Janssen, L. M. E., Ramsay, E. E., Logsdon, C. D., & Overwijk, W. W. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0283-9 · Cited by 292
Metadata
- Authors
- Nausch, N., & Cerwenka, A.
- Venue
- Oncogene
- Published
- 2008-10-06
- Volume
- 27
- Issue
- 45
- Pages
- 5944-5958
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2087569038
- Cited by
- 408
- References
- 146
- FWCI
- 7.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.